Douwe de Boer

Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human

Helena Carmo, Jan G. Hengstler, Douwe de Boer et al. · Toxicology · 2004 · 85 citations

Life Sciences, Biochemistry, Pharmacology +8

Influence of CYP2D6 polymorphism on 3,4-methylenedioxymethamphetamine (‘Ecstasy’) cytotoxicity

Helena Carmo, Marc Brulport, Matthias Hermes et al. · Pharmacogenetics and Genomics · 2006 · 49 citations

Pharmacy, Pharmacology, Toxicology +17

Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse

Helena Carmo, Jan G. Hengstler, Douwe de Boer et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2003 · 41 citations

Pharmacy, Pharmacology, Toxicology +13

Survival After Massive Ecstasy Overdose

S Ramcharan, P. L. Meenhorst, Jmmb Otten et al. · Journal of Toxicology Clinical Toxicology · 1998 · 40 citations

Pharmacy, Pharmacology, Toxicology +17

Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration

Helena Carmo, Douwe de Boer, Fernando Remião et al. · Journal of Chromatography B · 2004 · 32 citations

Medicine, Pharmacokinetics, Pharmacology +10